Pfizer Analysis Makes Case For COVID Vaccine Booster

Posted by on September 15, 2021 9:16 am
Categories: US National Stories

A health care worker administered a third dose of the Pfizer-BioNTech Covid-19 vaccine at a senior living facility in Worcester, Penn., in August.

Pfizer says data support its request for Food and Drug Administration approval of a third dose of COVID vaccine about six months after the second dose in people 16 years and older.

(Image credit: Bloomberg/Bloomberg via Getty Images)

Leave a Reply

Your email address will not be published. Required fields are marked *